You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 8, August 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Alternate-Day Prednisone Therapy in Recipients of Renal Allografts

Risks and Benefits

Arnold G. Diethelm, MD; William A. Sterling, MD; Marshall W. Hartley, PhD; Jean M. Morgan, MD

Arch Surg. 1976;111(8):867-870.


Abstract

• Forty-five patients receiving renal allografts were gradually converted from daily to alternate-day prednisone therapy. Indications for conversion included aseptic necrosis, growth retardation in children and adolescents, obesity, diabetes, cataract formation, and cosmetic appearance. Eight of the 45 patients developed acute or chronic rejection during or just after completion of alternate-day steroid therapy. The remaining 37 patients had a notable decrease in the degree of hypercorticism, with return of growth in children and adolescents. However, there was no improvement once aseptic necrosis or cataract formation had occurred. Although the use of alternate-day prednisone therapy is of benefit in reducing the untoward side effects of corticosteroids, the risk of precipitating allograft rejection is a significant threat and must be carefully considered whenever this form of treatment is undertaken.

(Arch Surg 111:867-870, 1976)



Author Affiliations

From the departments of surgery (Drs Diethelm, Sterling, and Morgan) and pathology (Dr Hartley), University of Alabama Medical Center, and the Veterans Administration Hospital, Birmingham. Dr Sterling is now with the Department of Surgery, University of New Mexico School of Medicine, Albuquerque.


Footnotes

Accepted for publication March 16, 1976.

Reprint requests to Department of Surgery, University of Alabama Medical Center, University Station, Birmingham, AL 35294 (Dr Diethelm).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Association of Hepatitis C with Posttransplant Diabetes in Renal Transplant Patients on Tacrolimus
Bloom et al.
J. Am. Soc. Nephrol. 2002;13:1374-1380.
ABSTRACT | FULL TEXT  

Alternate-Day Steroid Therapy for Renal Transplant Patients
Wohlman et al.
JAMA 1981;245:2493-2494.
ABSTRACT  

Stability of Renal Transplant Function With Alternate-Day Corticosteroid Therapy
Breitenfield et al.
JAMA 1980;244:151-156.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.